{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:59Z","timestamp":1786980179380,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00428-023-03532-7","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T06:06:22Z","timestamp":1680069982000},"page":"141-146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mixed mucinous adenocarcinoma\/large cell neuroendocrine carcinoma of the uterine cervix: case report and molecular characterization of a rare entity"],"prefix":"10.1007","volume":"484","author":[{"given":"Caterina","family":"Fattorini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno J.","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Arganini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Perotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cavazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-6902","authenticated-orcid":false,"given":"Maria R.","family":"Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Volante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"3532_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.pvr.2018.03.005","volume":"5","author":"M Alejo","year":"2018","unstructured":"Alejo M, Alemany L, Clavero O et al (2018) Contribution of human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases. Papillomavirus Res 5:134\u2013142. https:\/\/doi.org\/10.1016\/j.pvr.2018.03.005","journal-title":"Papillomavirus Res"},{"issue":"Suppl 2","key":"3532_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.12611","volume":"143","author":"N Bhatla","year":"2018","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R (2018) Cancer of the cervix uteri. Int J Gynaecol Obstet 143(Suppl 2):22\u201336. https:\/\/doi.org\/10.1002\/ijgo.12611","journal-title":"Int J Gynaecol Obstet"},{"key":"3532_CR3","doi-asserted-by":"crossref","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C (2016) Union for International Cancer Control: The TNM Classification of Malignant Tumours (8th edition)","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"issue":"2","key":"3532_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ygyno.2017.12.001","volume":"148","author":"PE Castle","year":"2018","unstructured":"Castle PE, Pierz A, Stoler MH (2018) A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix. Gynecol Oncol 148(2):422\u2013429. https:\/\/doi.org\/10.1016\/j.ygyno.2017.12.001","journal-title":"Gynecol Oncol"},{"issue":"5","key":"3532_CR5","doi-asserted-by":"publisher","first-page":"8095","DOI":"10.18632\/oncotarget.14098","volume":"8","author":"SY Cho","year":"2017","unstructured":"Cho SY, Choi M, Ban HJ et al (2017) Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing. Oncotarget 8(5):8095\u20138104. https:\/\/doi.org\/10.18632\/oncotarget.14098","journal-title":"Oncotarget"},{"key":"3532_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.15562\/bmj.v9i3.1940","volume":"9","author":"IG Dewi","year":"2020","unstructured":"Dewi IG (2020) Uterine cervix mixed adenoneuroendocrine carcinoma: case report of a rare, high grade and aggressive tumor. Bali Med J 9:587","journal-title":"Bali Med J"},{"key":"3532_CR7","doi-asserted-by":"publisher","unstructured":"Eskander RN, Elvin J, Gay L, Ross JS, Miller VA, Kurzrock R (2020) Unique genomic landscape of high-grade neuroendocrine cervical carcinoma: implications for rethinking current treatment paradigms. JCO Precis Oncol 4:PO.19.00248. Published 2020 Sep 3. https:\/\/doi.org\/10.1200\/PO.19.00248","DOI":"10.1200\/PO.19.00248"},{"issue":"2","key":"3532_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4274\/tjod.72325","volume":"13","author":"E Fad\u0131lo\u011flu","year":"2016","unstructured":"Fad\u0131lo\u011flu E, Karal\u00f6k A, T\u00fcrkmen O et al (2016) Amphricrine carcinoma of the cervix-adeno neuroendocrine tumor: a case report. Turk J Obstet Gynecol 13(2):99\u2013102. https:\/\/doi.org\/10.4274\/tjod.72325","journal-title":"Turk J Obstet Gynecol"},{"issue":"1","key":"3532_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","volume":"122","author":"GJ Gardner","year":"2011","unstructured":"Gardner GJ, Reidy-Lagunes D, Gehrig PA (2011) Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol 122(1):190\u2013198. https:\/\/doi.org\/10.1016\/j.ygyno.2011.04.011","journal-title":"Gynecol Oncol"},{"key":"3532_CR10","unstructured":"Globocan: Global Cancer Observatory. IARC. World Health Organization. (https:\/\/gco.iarc.fr\/, latest access July 2022)"},{"issue":"9","key":"3532_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11912-017-0617-2","volume":"19","author":"BE Howitt","year":"2017","unstructured":"Howitt BE, Kelly P, McCluggage WG (2017) Pathology of neuroendocrine tumours of the female genital tract. Curr Oncol Rep 19(9):59. https:\/\/doi.org\/10.1007\/s11912-017-0617-2","journal-title":"Curr Oncol Rep"},{"key":"3532_CR12","doi-asserted-by":"publisher","unstructured":"Inzani F, Santoro A, Angelico G et al (2020) Neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and immunohistochemical study with focus on novel markers (Sst2-Sst5). Cancers (Basel) 12(5):1211. Published 2020 May 12. https:\/\/doi.org\/10.3390\/cancers12051211","DOI":"10.3390\/cancers12051211"},{"key":"3532_CR13","doi-asserted-by":"publisher","unstructured":"Lyons YA, Frumovitz M, Soliman PT (2014) Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation. Gynecol Oncol Rep 10:28\u201329. Published 2014 Oct 25. https:\/\/doi.org\/10.1016\/j.gore.2014.09.003","DOI":"10.1016\/j.gore.2014.09.003"},{"issue":"3","key":"3532_CR14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/PAS.0000000000000093","volume":"38","author":"A Matsubara","year":"2014","unstructured":"Matsubara A, Sekine S, Ogawa R et al (2014) Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations. Am J Surg Pathol 38(3):370\u2013376. https:\/\/doi.org\/10.1097\/PAS.0000000000000093","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3532_CR15","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3126\/jpn.v10i2.28736","volume":"10","author":"M Meel","year":"2020","unstructured":"Meel M, Jindal A, Kumar M, Mittal A (2020) Small cell neuroendocrine carcinoma coexisting with adenocarcinoma of the uterine cervix - a rare entity. J Pathol Nepal 10(2):1783\u20131785. https:\/\/doi.org\/10.3126\/jpn.v10i2.28736","journal-title":"J Pathol Nepal"},{"issue":"12","key":"3532_CR16","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1097\/PAS.0000000000001943","volume":"46","author":"Z Ordulu","year":"2022","unstructured":"Ordulu Z, Mino-Kenudson M, Young RH et al (2022) Morphologic and molecular heterogeneity of cervical neuroendocrine neoplasia: a report of 14 cases. Am J Surg Pathol 46(12):1670\u20131681. https:\/\/doi.org\/10.1097\/PAS.0000000000001943","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"3532_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1053\/j.semdp.2013.06.007","volume":"30","author":"M Rouzbahman","year":"2013","unstructured":"Rouzbahman M, Clarke B (2013) Neuroendocrine tumors of the gynecologic tract: select topics. Semin Diagn Pathol 30(3):224\u2013233. https:\/\/doi.org\/10.1053\/j.semdp.2013.06.007","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"3532_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1634\/theoncologist.2016-0517","volume":"22","author":"A Sharabi","year":"2017","unstructured":"Sharabi A, Kim SS, Kato S et al (2017) exceptional response to nivolumab and stereotactic body radiation therapy (SBRT) in neuroendocrine cervical carcinoma with high tumor mutational burden: management considerations from the center for personalized cancer therapy at UC San Diego Moores Cancer Center. Oncologist 22(6):631\u2013637. https:\/\/doi.org\/10.1634\/theoncologist.2016-0517","journal-title":"Oncologist"},{"key":"3532_CR19","doi-asserted-by":"publisher","unstructured":"Tempfer CB, Tischoff I, Dogan A et al (2018) Neuroendocrine carcinoma of the cervix: a systematic review of the literature. BMC Cancer 18(1):530. Published 2018 May 4. https:\/\/doi.org\/10.1186\/s12885-018-4447-x","DOI":"10.1186\/s12885-018-4447-x"},{"key":"3532_CR20","unstructured":"WHO (2020) Classification of Tumours Editorial Board. Female genital tumours. Lyon (France): International Agency for Research on Cancer (WHO classification of tumours series, 5th ed.; vol. 4). https:\/\/publications.iarc.fr\/592"},{"issue":"6","key":"3532_CR21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/PAS.0000000000001042","volume":"42","author":"D Xing","year":"2018","unstructured":"Xing D, Zheng G, Schoolmeester JK et al (2018) Next-generation sequencing reveals recurrent somatic mutations in small cell neuroendocrine carcinoma of the uterine cervix. Am J Surg Pathol 42(6):750\u2013760. https:\/\/doi.org\/10.1097\/PAS.0000000000001042","journal-title":"Am J Surg Pathol"},{"issue":"45","key":"3532_CR22","doi-asserted-by":"publisher","first-page":"22730","DOI":"10.1073\/pnas.1911385116","volume":"116","author":"L Zammataro","year":"2019","unstructured":"Zammataro L, Lopez S, Bellone S et al (2019) Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy. Proc Natl Acad Sci U S A 116(45):22730\u201322736. https:\/\/doi.org\/10.1073\/pnas.1911385116","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03532-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-023-03532-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03532-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T11:40:55Z","timestamp":1744198855000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-023-03532-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["3532"],"URL":"https:\/\/doi.org\/10.1007\/s00428-023-03532-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"7 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent for publication was obtained from all authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}